Galectin-3 (Gal-3) is a fibrosis biomarker that is involved in the initiation and progression of many fibrosis related diseases, such as heart failure (HF), live cirrhosis, and lung fibrosis [9, 10]. Here, LGALS3 is linked to heart failure.